Revised Tubiana's staging system for assessment of disease severity in Dupuytren's disease-preliminary clinical findings
- PMID: 18780081
- PMCID: PMC2529142
- DOI: 10.1007/s11552-007-9071-1
Revised Tubiana's staging system for assessment of disease severity in Dupuytren's disease-preliminary clinical findings
Abstract
There are few objective staging systems to assess severity of Dupuytren's disease (DD). Previous methods to assess severity of DD were based primarily on the degree of contracture of an affected digit measured using a goniometer. Nonetheless, this method of assessment alone may be incomplete, and other factors should be considered. White (n = 92) patients diagnosed with DD from northwest of England were assessed for DD. Objective criteria for evaluating severity incorporated quantified variables. The revised severity stage was correlated to a known staging system of DD (Tubiana's staging system) which measures total flexion deformity for a single affected digit. Total revised severity staging scores ranged between 4 and 53 (mean = 18.7) and revealed significant positive correlation to Tubiana's original staging system (r (2) = 0.8, p < 0.001). There was significant difference between severity staging scores in those with a positive family history compared to those without (p < 0.01). In current practice, often, the degree of contracture in an affected digit is used solely as a measure of disease severity. Additional objective clinical information may provide useful prognostic indices for disease progression as well as postoperative outcome.
Figures



Similar articles
-
Hand Function Deficiency in Patients with Dupuytren's Disease and Course of Recovery after Palmar Fasciectomy.Acta Chir Orthop Traumatol Cech. 2019;86(3):193-198. Acta Chir Orthop Traumatol Cech. 2019. PMID: 31333183 English.
-
Dupuytren's contracture: clinical and therapeutic aspects.Ital J Orthop Traumatol. 1980 Aug;6(2):219-34. Ital J Orthop Traumatol. 1980. PMID: 7216725
-
Current Smoking Is Associated with Delayed Wound Healing But Not with Improvement of Contracture after the Open Palm Technique for Dupuytren's Disease.J Hand Surg Asian Pac Vol. 2019 Mar;24(1):65-71. doi: 10.1142/S2424835519500127. J Hand Surg Asian Pac Vol. 2019. PMID: 30760148
-
Collagenase Clostridium histolyticum -- Benefit Assessment According to §35a Social Code Book V [Internet].Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2012 Jan 30. Extract of Dossier Assessment No. A11-27. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2012 Jan 30. Extract of Dossier Assessment No. A11-27. PMID: 27905729 Free Books & Documents. Review.
-
Dupuytren's disease: history, diagnosis, and treatment.Plast Reconstr Surg. 2007 Sep;120(3):44e-54e. doi: 10.1097/01.prs.0000278455.63546.03. Plast Reconstr Surg. 2007. PMID: 17700106 Review.
Cited by
-
Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren's contracture.World J Orthop. 2018 Sep 18;9(9):130-137. doi: 10.5312/wjo.v9.i9.130. eCollection 2018 Sep 18. World J Orthop. 2018. PMID: 30254969 Free PMC article.
-
Dupuytren's Contracture: A Review of the Literature.Cureus. 2024 Dec 2;16(12):e74945. doi: 10.7759/cureus.74945. eCollection 2024 Dec. Cureus. 2024. PMID: 39744282 Free PMC article. Review.
-
The Ability of Patients to Provide Standardized, Patient-Taken Photographs for the Remote Assessment of Dupuytren Disease.Hand (N Y). 2023 Jan;18(1):139-144. doi: 10.1177/15589447211006834. Epub 2021 Apr 15. Hand (N Y). 2023. PMID: 33855895 Free PMC article.
-
Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.BMC Musculoskelet Disord. 2011 May 25;12:113. doi: 10.1186/1471-2474-12-113. BMC Musculoskelet Disord. 2011. PMID: 21612641 Free PMC article.
-
Angiotensin Receptor Autoantibodies in Dupuytren Disease: A Biomarker Study.Plast Surg (Oakv). 2025 Jun 5:22925503251344305. doi: 10.1177/22925503251344305. Online ahead of print. Plast Surg (Oakv). 2025. PMID: 40486928 Free PMC article.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15336743', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15336743/'}]}
- Abe Y, Rokkaku S, Ofuchi S, Tokunaga S, Takahashi K, Moriya H. An objective method to evaluate the risk of recurrence and extension of Dupuytren’s disease. J Hand Surg (Br) 2004;29-B(5):427–30. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15142693', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15142693/'}]}
- Abe Y, Rokkaku S, Ofuchi S, Tokunaga S, Takahashi K, Moriya H. Surgery for Dupuytren’s disease in Japanese patients and a new preoperative classification. J Hand Surg (Br) 2004;29-B(3):233–7. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '6747420', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/6747420/'}]}
- Arafa M, Steingold RF, Noble J. The incidence of Dupuytren’s disease in patients with rheumatoid arthritis. J Hand Surg (Br) 1984;9-B:165–6. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8697659', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8697659/'}]}
- Arkkila PE, Kantola IM, Viikari JS, Ronnemaa T, Vahatalo MA. Dupuytren’s disease in type I diabetic patients: a five year prospective study. Clin Exp Rheumatol 1996;14:59–65. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9002027', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9002027/'}]}
- Arkkila PE, Kantola IM, Viikari JS. Dupuytren’s disease: association with chronic diabetic complications. J Rheumatol 1997;24:153–9. - PubMed
LinkOut - more resources
Full Text Sources